No­var­tis to cut up to 400 jobs at Dublin cam­pus

Weeks af­ter CEO Vas Narasimhan un­veiled a “US-first” strat­e­gy in re­shap­ing No­var­tis, the Swiss phar­ma gi­ant has re­vealed plans to cut around 400 jobs at its Dublin cam­pus by the end of 2024.

The cuts are part of a ma­jor re­struc­tur­ing that Narasimhan ini­ti­at­ed back in April, cut­ting out $1 bil­lion in costs and let­ting go of some key ex­ecs while com­bin­ing the phar­ma­ceu­ti­cals and on­col­o­gy units un­der one roof. In an at­tempt to achieve a “lean­er and sim­pler” busi­ness, No­var­tis is chop­ping 8,000 of 108,000 cur­rent roles world­wide, a spokesper­son told End­points News on Thurs­day.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.